Cited in:


This article has been cited by:

  1. 1
    Leechuan Andy Chen, Christopher J. Anker, Jason P. Hunt, Luke O. Buchmann, Kenneth F. Grossmann, Kenneth Boucher, Li-Ming Christine Fang, Dennis C. Shrieve, Ying J. Hitchcock, Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience, Cancer Medicine, 2015, 4, 5
  2. 2
    Sonia S. Lin, Sean T. Massa, Mark A. Varvares, Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases, Head & Neck, 2015, 37, 6
  3. 3
    Georgios Psychogios, Konstantinos Mantsopoulos, Abbas Agaimy, Kathrin Brunner, Elisabeth Mangold, Johannes Zenk, Heinrich Iro, Outcome and Prognostic Factors in T4a Oropharyngeal Carcinoma, Including the Role of HPV Infection, BioMed Research International, 2014, 2014, 1


  4. 4
    Georgios Psychogios, Konstantinos Mantsopoulos, Christopher Bohr, Michael Koch, Johannes Zenk, Heinrich Iro, Incidence of occult cervical metastasis in head and neck carcinomas: Development over time, Journal of Surgical Oncology, 2013, 107, 4
  5. 5
    Georgios Psychogios, Konstantinos Mantsopoulos, Abbas Agaimy, Michael Koch, Johannes Zenk, Frank Waldfahrer, Heinrich Iro, Prognostic factors in limited (T1–2, N0–1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy, Head & Neck, 2013, 35, 12